Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
Our progress would not be possible without our donor community. Help support our mission by giving today.
Texas Heart Institute, Dell Children’s Medical Center and UT Health Austin partner to launch innovative educational program for training the...
Having a heart attack can lead to stress, anxiety, and depression, and patients are terrified afterward that they are going...
February is the month when focus turns to the heart, and this year marks American Heart Month’s 57th annual nationwide...
Ronald J. Biediger, Ph.D., a visionary scientist, and inventor, and a highly respected member of the Texas Heart Institute and the...
The Houston Chronicle is celebrating the 175th birthday of Texas with a special series aimed to illuminate the state’s diverse,...
Innovation Map interviews Dr. Mehdi Razavi about his Create the Future Design contest-winning product design entry. The magazine also recognized...
Texas Monthly’s annual SUPER DOCTORS® list is out on the newsstands this month and honors professionals who are recognized by...
Researchers at the Texas Heart Institute (THI) working with a team of engineers at the University of Houston led by...
Today more than 30 million patients suffer from painful inflammatory conditions. Prescription opioid pain relievers are commonly prescribed for these...
